Literature DB >> 23318434

Dual regulation of Myc by Abl.

V J Sanchez-Arévalo Lobo1, M Doni, A Verrecchia, S Sanulli, G Fagà, A Piontini, M Bianchi, M Conacci-Sorrell, G Mazzarol, V Peg, J H Losa, P Ronchi, M Ponzoni, R N Eisenman, C Doglioni, B Amati.   

Abstract

The tyrosine kinase c-Abl (or Abl) and the prolyl-isomerase Pin1 cooperatively activate the transcription factor p73 by enhancing recruitment of the acetyltransferase p300. As the transcription factor c-Myc (or Myc) is a known target of Pin1 and p300, we hypothesized that it might be regulated in a similar manner. Consistent with this hypothesis, overexpression of Pin1 augmented the interaction of Myc with p300 and transcriptional activity. The action of Abl, however, was more complex than predicted. On one hand, Abl indirectly enhanced phosphorylation of Myc on Ser 62 and Thr 58, its association with Pin1 and p300 and its acetylation by p300. These effects of Abl were exerted through phosphorylation of substrate(s) other than Myc itself. On the other hand, Abl interacted with the C-terminal domain of Myc and phosphorylated up to five tyrosine residues in its N-terminus, the principal of which was Y74. Indirect immunofluorescence or immunohistochemical staining suggested that the Y74-phosphorylated form of Myc (Myc-pY74) localized to the cytoplasm and coexisted either with active Abl in a subset of mammary carcinomas or with Bcr-Abl in chronic myeloid leukemia. In all instances, Myc-pY74 constituted a minor fraction of the cellular Myc protein. Thus, our data unravel two potential effects of Abl on Myc: first, Abl signaling can indirectly augment acetylation of Myc by p300, and most likely also its transcriptional activity in the nucleus; second, Abl can directly phosphorylate Myc on tyrosine: the resulting form of Myc appears to be cytoplasmic, and its presence correlates with Abl activation in cancer.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23318434      PMCID: PMC3914638          DOI: 10.1038/onc.2012.621

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  43 in total

1.  A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells.

Authors:  Elizabeth Yeh; Melissa Cunningham; Hugh Arnold; Dawn Chasse; Teresa Monteith; Giovanni Ivaldi; William C Hahn; P Todd Stukenberg; Shirish Shenolikar; Takafumi Uchida; Christopher M Counter; Joseph R Nevins; Anthony R Means; Rosalie Sears
Journal:  Nat Cell Biol       Date:  2004-03-14       Impact factor: 28.824

2.  Function of WW domains as phosphoserine- or phosphothreonine-binding modules.

Authors:  P J Lu; X Z Zhou; M Shen; K P Lu
Journal:  Science       Date:  1999-02-26       Impact factor: 47.728

3.  Abnormal distribution of c-myc oncogene product in familial adenomatous polyposis.

Authors:  V Sundaresan; I C Forgacs; D G Wight; B Wilson; G I Evan; J V Watson
Journal:  J Clin Pathol       Date:  1987-11       Impact factor: 3.411

4.  Immunohistochemical demonstration of altered intracellular localization of the C-Myc oncogene product in human colorectal neoplasms.

Authors:  A R Williams; J Piris; A H Wyllie
Journal:  J Pathol       Date:  1990-04       Impact factor: 7.996

5.  The BCR-ABL oncogene transforms Rat-1 cells and cooperates with v-myc.

Authors:  T G Lugo; O N Witte
Journal:  Mol Cell Biol       Date:  1989-03       Impact factor: 4.272

6.  Altered cytoplasmic/nuclear distribution of the c-myc protein in differentiating ML-1 human myeloid leukemia cells.

Authors:  R W Craig; H L Buchan; C I Civin; M B Kastan
Journal:  Cell Growth Differ       Date:  1993-05

7.  Dominant negative MYC blocks transformation by ABL oncogenes.

Authors:  C L Sawyers; W Callahan; O N Witte
Journal:  Cell       Date:  1992-09-18       Impact factor: 41.582

8.  Functional analysis of the AUG- and CUG-initiated forms of the c-Myc protein.

Authors:  E M Blackwood; T G Lugo; L Kretzner; M W King; A J Street; O N Witte; R N Eisenman
Journal:  Mol Biol Cell       Date:  1994-05       Impact factor: 4.138

9.  Activation of p38 mitogen-activated protein kinase by c-Abl-dependent and -independent mechanisms.

Authors:  P Pandey; J Raingeaud; M Kaneki; R Weichselbaum; R J Davis; D Kufe; S Kharbanda
Journal:  J Biol Chem       Date:  1996-09-27       Impact factor: 5.157

10.  Pin1 links the activities of c-Abl and p300 in regulating p73 function.

Authors:  Fiamma Mantovani; Silvano Piazza; Monica Gostissa; Sabrina Strano; Paola Zacchi; Roberto Mantovani; Giovanni Blandino; Giannino Del Sal
Journal:  Mol Cell       Date:  2004-06-04       Impact factor: 17.970

View more
  17 in total

Review 1.  Regulation of transcription factor activity by interconnected post-translational modifications.

Authors:  Theresa M Filtz; Walter K Vogel; Mark Leid
Journal:  Trends Pharmacol Sci       Date:  2013-12-30       Impact factor: 14.819

2.  FBXO32 Targets c-Myc for Proteasomal Degradation and Inhibits c-Myc Activity.

Authors:  Zhichao Mei; Dawei Zhang; Bo Hu; Jing Wang; Xian Shen; Wuhan Xiao
Journal:  J Biol Chem       Date:  2015-05-05       Impact factor: 5.157

Review 3.  Charting Immune Signaling Proteomes En Route to New Therapeutic Strategies.

Authors:  Eric B Haura; Amer A Beg; Uwe Rix; Scott Antonia
Journal:  Cancer Immunol Res       Date:  2015-06-16       Impact factor: 11.151

4.  Bafetinib Suppresses the Transcription of PD-L1 Through c-Myc in Lung Cancer.

Authors:  Xi Chen; Qianqian Du; Hongjie Guo; Qiaojun He; Bo Yang; Ling Ding
Journal:  Front Pharmacol       Date:  2022-06-02       Impact factor: 5.988

Review 5.  The impact of phosphatases on proliferative and survival signaling in cancer.

Authors:  Goutham Narla; Jaya Sangodkar; Christopher B Ryder
Journal:  Cell Mol Life Sci       Date:  2018-05-03       Impact factor: 9.261

6.  Pin1 regulates the dynamics of c-Myc DNA binding to facilitate target gene regulation and oncogenesis.

Authors:  Amy S Farrell; Carl Pelz; Xiaoyan Wang; Colin J Daniel; Zhiping Wang; Yulong Su; Mahnaz Janghorban; Xiaoli Zhang; Charlie Morgan; Soren Impey; Rosalie C Sears
Journal:  Mol Cell Biol       Date:  2013-05-28       Impact factor: 4.272

7.  Non-receptor-tyrosine kinases integrate fast glucocorticoid signaling in hippocampal neurons.

Authors:  Silei Yang; Francesco Roselli; Alexandre V Patchev; Shuang Yu; Osborne F X Almeida
Journal:  J Biol Chem       Date:  2013-07-01       Impact factor: 5.157

Review 8.  MYC degradation.

Authors:  Amy S Farrell; Rosalie C Sears
Journal:  Cold Spring Harb Perspect Med       Date:  2014-03-01       Impact factor: 6.915

9.  Genomic quantitative real-time PCR proves residual disease positivity in more than 30% samples with negative mRNA-based qRT-PCR in Chronic Myeloid Leukemia.

Authors:  Ilaria S Pagani; Orietta Spinelli; Elia Mattarucchi; Cristina Pirrone; Diana Pigni; Elisabetta Amelotti; Silvia Lilliu; Chiara Boroni; Tamara Intermesoli; Ursula Giussani; Luigi Caimi; Federica Bolda; Renata Baffelli; Eleonora Candi; Francesco Pasquali; Francesco Lo Curto; Arnalda Lanfranchi; Fulvio Porta; Alessandro Rambaldi; Giovanni Porta
Journal:  Oncoscience       Date:  2014-07-23

10.  ABL1, Overexpressed in Hepatocellular Carcinomas, Regulates Expression of NOTCH1 and Promotes Development of Liver Tumors in Mice.

Authors:  Fang Wang; Wei Hou; Lennox Chitsike; Yingchen Xu; Carlee Bettler; Aldeb Perera; Thomas Bank; Scott J Cotler; Asha Dhanarajan; Mitchell F Denning; Xianzhong Ding; Peter Breslin; Wenan Qiang; Jun Li; Anthony J Koleske; Wei Qiu
Journal:  Gastroenterology       Date:  2020-06-24       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.